insights_auto
Why is PEB down 2.17%?
Dive Deeperchevron_right
PEB:ASX
Pacific Edge Ltd
A$0.22
arrow_downward
-2.17%(-0.0050) 1D
Nov 16, 1:22:05 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEB...
Open
A$0.23
High
A$0.23
Low
A$0.22
Mkt. cap
348.73M
Avg. vol.
54.06K
Volume
10.10K
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
Open
A$0.23
High
A$0.23
Low
A$0.22
Mkt. cap
348.73M
Avg. vol.
54.06K
Volume
10.10K
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
News stories
From web sources and news partners
BigGo Finance
·
16 hours ago
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
11 hours ago
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
TradingKey
·
1 day ago
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
StoneX
·
2 days ago
S&P 500, Nasdaq 100 Claw Back But NVDA Cloud Looms Overhead
Profile
Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the Australian ASX and the New Zealand NZX main board stock exchange. Wikipedia
About Pacific Edge Ltd
CEO-
Employees114
Founded2001
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitepacificedgedx.com